<DOC>
	<DOCNO>NCT00116896</DOCNO>
	<brief_summary>This Phase I , open-label , dose escalation , study combination cisplatin OSI-7904L give Day 1 every 21 day patient advance solid tumor .</brief_summary>
	<brief_title>Phase I Study Cisplatin Plus OSI-7904L Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Cisplatin</mesh_term>
	<criteria>18 year age old Advanced and/or metastatic solid tumor effective therapy available ECOG performance status 02 Adequate bone marrow , hepatic renal function Patients active uncontrolled infection Neurotoxicity &gt; = Grade 2 Symptomatic brain metastasis stable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2003</verification_date>
</DOC>